Minoxidil — $0 on Listed Strengths

Minoxidil is $0 on listed strengths only. Other strengths are not a blanket $0.

Minoxidil Pricing

Pricing type	Price
TheDrugClub	$0 on listed strengths
Typical Retail	$31.00

$0 on listed strengths: 10mg Tablets (max 90); 2.5mg Tablets (max 360)

About Minoxidil

Minoxidil is a prescription medication. Ask your doctor if Minoxidil is right for you.

How to Check Minoxidil Pricing

Join TheDrugClub for $19.95/month
Receive your member card by email
Present your card at a participating pharmacy
Check active-formulary eligibility or available membership pricing

Minoxidil at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

What Minoxidil is approved for (FDA label)

Because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. At the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. Minoxidil reduced supine diastolic blood pressure by 20 mm Hg or to 90 mm Hg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs.

Source: Read the full FDA label on DailyMed. Label effective date: August 25, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Minoxidil (FDA label)

WARNINGS Minoxidil tablets contain the powerful antihypertensive agent, minoxidil, which may produce serious adverse effects. It can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated. Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents. In experimental animals, minoxidil caused several kinds of myocardial lesions as well as other adverse cardiac effects (see Cardiac Lesions in Animals ). Minoxidil must be administered under close supervision, usually concomitantly with therapeutic doses of a beta-adrenergic blocking agent to prevent tachycardia and increased myocardial workload. It must also usually be given with a diuretic, frequently one acting in the ascending limb of the loop of Henle, to prevent serious fluid accumulation. Patients with malignant hypertension and those already receiving guanethidine (see WARNINGS ) should be hospitalized when minoxidil is first administered so that they can be monitored to avoid too rapid, or large orthostatic, decreases in blood pressure.

Source: FDA prescribing information (DailyMed). Set ID: 0b4fc036-9497-442b-b629-c4b386932789. SPL document ID: 59e01b3f-17d8-badc-e063-6294a90a3245. Label effective date: August 25, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Minoxidil (FDA label)

Salt and Water Retention (see WARNINGS: Concomitant Use of Adequate Diuretic is Required ) – Temporary edema developed in 7% of patients who were not edematous at the start of therapy. Pericarditis, Pericardial Effusion and Tamponade (see WARNINGS ). Dermatologic – Hypertrichosis – Elongation, thickening, and enhanced pigmentation of fine body hair are seen in about 80% of patients taking minoxidil tablets. This develops within 3 to 6 weeks after starting therapy. It is usually first noticed on the temples, between the eyebrows, between the hairline and the eyebrows, or in the side-burn area of the upper lateral cheek, later extending to the back, arms, legs, and scalp.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Minoxidil (FDA label)

Minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. Minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial